Enflame Plans $892 Million Shanghai IPO, Offering 43 Million Shares as China’s AI Chip Race Heats Up
Key Points
$892M IPO: Enflame targets 6 billion yuan from its Shanghai listing.
43.04M shares: New shares equal 10% of enlarged share capital.
AI chip focus: Funds will support fifth- and sixth-generation AI chips.
Key risks: Heavy Tencent reliance, losses, and strong domestic competition remain concerns.
China’s AI chip race is entering another busy phase as Enflame Technology targets a 6 billion yuan ($892 million) Shanghai IPO. The Tencent-backed chipmaker plans to issue 43.04 million new shares, with subscriptions set to open on September 2, 2026. Price consultations will start on August 28. The offering comes as Chinese AI chipmakers draw more investor attention and Beijing continues to support domestic semiconductor development. Could Enflame become one of the next major names in China’s AI chip market?
Enflame IPO Details: 43 Million Shares and a $892 Million Fundraising Target
Enflame Technology is preparing for one of China’s notable AI-chip listings in 2026. The Shanghai-based company plans to raise 6 billion yuan ($892.21 million) through its STAR Market IPO. It will issue 43.04 million new shares, which equal 10% of its enlarged share capital of about 430 million shares. Existing shareholders will not sell shares as part of the offering.
Key Numbers Investors Need to Know
The planned allocation shows how the IPO will be divided among different investor groups:
- Total fundraising: 6 billion yuan ($892.21 million)
- New shares: 43.04 million
- Strategic investors: 8.61 million
- Institutional investors: 27.54 million
- Retail investors: 6.89 million
CITIC Securities is leading the deal. Guotai Haitong Securities and GF Securities are joint underwriters.
Shanghai STAR Market Listing Timeline
Enflame will start preliminary price consultations on August 28, 2026. Investors will then be able to subscribe for shares from September 2. The listing will give Enflame access to Shanghai’s technology-focused STAR Market, which has become a major funding channel for Chinese semiconductor companies.
Why Enflame Matters in China’s Domestic AI Chip Race?
From Startup to China’s “Four Little GPU Dragons”
Founded in 2018, Enflame has developed into a major Chinese AI-chip company. It is often grouped with Moore Threads, MetaX and Biren Technology as one of China’s “four little GPU dragons.” These companies are developing domestic options for AI training and inference as China works to reduce its reliance on overseas computing technology.
Tencent Backing Adds Strategic Weight
Tencent remains a major shareholder and an important commercial partner for Enflame. Its relationship with the chipmaker connects Enflame to one of China’s largest technology ecosystems.
That backing also comes with a clear risk. Enflame generated 83.8% of its 2025 revenue from Tencent, according to Caixin. A high share of revenue from one customer can leave a company exposed if that relationship changes.
Where the $892 Million Enflame IPO Proceeds Will Go?
Enflame plans to direct the IPO proceeds towards its next generation of AI chips. The company will use the funds to develop and commercialise its fifth- and sixth-generation AI chips. It also plans to invest in advanced AI software-hardware integration.
Earlier prospectus details put the planned investment at about 1.5 billion yuan for fifth-generation chips and 1.2 billion yuan for sixth-generation chips.
AI-chip competition depends on more than processing hardware. Software support, developer tools, and system integration can affect how easily customers adopt a new accelerator and use it in their existing systems.
China’s AI IPO Boom Raises Both Opportunity and Valuation Risks
Domestic Chip Listings are Accelerating
Enflame’s planned listing comes as China continues to strengthen its domestic semiconductor sector. The Shanghai Stock Exchange has reported a faster flow of domestic chip IPOs in 2026. Enflame and CanSemi both cleared IPO reviews in June, with combined planned fundraising of 13.5 billion yuan.
Policy support remains a major factor behind the interest in domestic semiconductor companies. Demand for local AI computing infrastructure is another.
The AI IPO Rally Comes With Bubble Concerns
Strong investor interest has also brought valuation concerns. Several Chinese technology IPOs have recorded sharp price swings. Reuters has reported concerns about a possible AI-market bubble following strong gains in recent listings.
For Enflame, investors will need to keep an eye on revenue growth, losses, and customer concentration. The company will also need to turn its research and development spending into products that gain wider commercial use.
What Enflame’s IPO Means for China’s AI Semiconductor Market?
Enflame is entering the public market with rapid revenue growth, but it has yet to reach profitability. Revenue rose to 990 million yuan in 2025, compared with 301 million yuan in 2023. The company still reported a 1.16 billion yuan net loss in 2025. Caixin reported that Enflame expects to reach profitability around 2026-2027.
China’s growing demand for domestic AI accelerators gives Enflame room to expand. The company also faces strong competition, high customer concentration, and the challenge of turning new technology into steady revenue.
Enflame Stock Forecast and Technical Analysis
Enflame is not yet publicly trading, so there is no reliable live share price, technical chart, or established analyst price target to report. Searches of Meyka also do not show an established Enflame stock-analysis page. It would be misleading to provide a Meyka rating, forecast, or technical signal that has not been published.
After Enflame begins trading, investors can use an AI stock analysis tool alongside traditional financial and technical research to assess price momentum, valuation and risk.
What Meyka Says?
There is currently no verified Enflame coverage on Meyka that supports a stock rating or forecast. The company’s IPO price has also not been finalised. Any pre-listing price target should be viewed as speculation rather than a confirmed analyst forecast.
Conclusion: Enflame’s IPO Is More Than a Fundraising Event
Enflame’s $892 million IPO comes as China continues to build its domestic AI-chip industry. The company plans to use the new capital for next-generation chips while dealing with competition and heavy losses. Its September 2, 2026 subscription date will provide an early indication of investor demand. Longer term, Enflame’s progress will depend on whether it can turn revenue growth and fresh funding into profits and broader customer adoption.
Disclaimer:
The content shared by Meyka AI PTY LTD is for research and informational purposes only. Meyka is not a financial advisory service, and the information provided should not be treated as investment or trading advice.
What brings you to Meyka?
Pick what interests you most and we will get you started.
I'm here to read news
Find more articles like this one
I'm here to research stocks
Ask Meyka Analyst about any stock
I'm here to track my Portfolio
Get daily updates and alerts (coming March 2026)